学术探索
学术期刊
新闻热点
数据分析
智能评审

FUTURE-DIRECTIONS IN THE MANAGEMENT OF SOFT-TISSUE SARCOMAS

被引：4
作者：
ELIAS, AD
机构：
[1] Division of Clinical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
来源：
HEMATOLOGICAL ONCOLOGY | 1992年 / 10卷 / 01期
关键词：
D O I：
10.1002/hon.2900100110
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：53 / 60
页数：8
相关论文
共 70 条
[1]   ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN IN HIGH-GRADE SOFT-TISSUE SARCOMA - A RANDOMIZED TRIAL OF THE SCANDINAVIAN-SARCOMA-GROUP [J].
ALVEGARD, TA ;
SIGURDSSON, H ;
MOURIDSEN, H ;
SOLHEIM, O ;
UNSGAARD, B ;
RINGBORG, U ;
DAHL, O ;
NORDENTOFT, AM ;
BLOMQVIST, C ;
RYDHOLM, A ;
STENER, B ;
RANSTAM, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1504-1513
[2]   PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT DOXORUBICIN FOR SARCOMAS - LACK OF APPARENT DIFFERENCE BETWEEN TREATMENT GROUPS [J].
ANTMAN, K ;
SUIT, H ;
AMATO, D ;
CORSON, J ;
WOOD, W ;
PROPPE, K ;
HARMON, D ;
CAREY, R ;
GREENBERGER, J ;
BLUM, R ;
WILSON, R .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :601-608
[3]  
ANTMAN K, 1985, CANCER TREAT S, V3, P109
[4]  
ANTMAN K, 1990, P AN M AM SOC CLIN, V9, P311
[5]  
ANTMAN K, 1987, ADJUVANT THERAPY CAN, V4, P725
[6]   RESPONSE TO IFOSFAMIDE AND MESNA - 124 PREVIOUSLY TREATED PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA [J].
ANTMAN, KH ;
RYAN, L ;
ELIAS, A ;
SHERMAN, D ;
GRIER, HE .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :126-131
[7]   CHEMOTHERAPY OF ADVANCED SOFT-TISSUE SARCOMAS [J].
ANTMAN, KH ;
ELIAS, AD .
SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01) :53-58
[8]  
ANTMAN KH, 1984, ADJUVANT THERAPY CAN, V4, P611
[9]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[10]  
BAKER A R, 1988, P123
1234567